StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) stock

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$3.20−0.36 (-10.11%)

Close on Nov 16, 2026Market cap $54.97MP/E –Yield –

Verrica Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Verrica Pharmaceuticals's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $41.69M in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$12.94M–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$41.69M+18.1%
FY2020Dec 31, 2020$35.32M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$12.46M–
Q2 FY2025Jun 30, 2025$12.67M–
Q1 FY2025Mar 31, 2025$12.82M–
Q4 FY2024Dec 31, 2024$12.94M-69.4%
Q4 FY2023Dec 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$42.29M+3.1%
Q1 FY2022Mar 31, 2022$42.00M+3.3%
Q4 FY2021Dec 31, 2021$41.69M+18.1%
Q3 FY2021Sep 30, 2021$41.35M+18.2%
Q2 FY2021Jun 30, 2021$41.01M+18.1%
Q1 FY2021Mar 31, 2021$40.67M–
Q4 FY2020Dec 31, 2020$35.32M–
Q3 FY2020Sep 30, 2020$34.98M–
Q2 FY2020Jun 30, 2020$34.72M–

More Verrica Pharmaceuticals figures

See a number that looks wrong?